ITUA20162425A1 - Composizione oftalmica che comprende PVP-I - Google Patents

Composizione oftalmica che comprende PVP-I

Info

Publication number
ITUA20162425A1
ITUA20162425A1 ITUA2016A002425A ITUA20162425A ITUA20162425A1 IT UA20162425 A1 ITUA20162425 A1 IT UA20162425A1 IT UA2016A002425 A ITUA2016A002425 A IT UA2016A002425A IT UA20162425 A ITUA20162425 A IT UA20162425A IT UA20162425 A1 ITUA20162425 A1 IT UA20162425A1
Authority
IT
Italy
Prior art keywords
pvp
ophthalmic composition
ophthalmic
composition
Prior art date
Application number
ITUA2016A002425A
Other languages
English (en)
Inventor
Danilo Aleo
Melina Cro
Sergio Mangiafico
Barbara MELILLI
Maria Grazia Saita
Original Assignee
Medivis S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivis S R L filed Critical Medivis S R L
Priority to ITUA2016A002425A priority Critical patent/ITUA20162425A1/it
Priority to MA044601A priority patent/MA44601A/fr
Priority to PCT/IB2017/050911 priority patent/WO2017175075A1/en
Priority to PL17714281.7T priority patent/PL3439631T3/pl
Priority to BR112018070734-1A priority patent/BR112018070734B1/pt
Priority to CN201780022544.XA priority patent/CN108883064B/zh
Priority to US16/092,173 priority patent/US20200000714A1/en
Priority to RU2018139074A priority patent/RU2740910C2/ru
Priority to AU2017247694A priority patent/AU2017247694B2/en
Priority to ES17714281T priority patent/ES2950498T3/es
Priority to MX2018012311A priority patent/MX385489B/es
Priority to EP17714281.7A priority patent/EP3439631B1/en
Priority to PT177142817T priority patent/PT3439631T/pt
Priority to CA3019748A priority patent/CA3019748C/en
Publication of ITUA20162425A1 publication Critical patent/ITUA20162425A1/it
Priority to CL2018002861A priority patent/CL2018002861A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ITUA2016A002425A 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I ITUA20162425A1 (it)

Priority Applications (15)

Application Number Priority Date Filing Date Title
ITUA2016A002425A ITUA20162425A1 (it) 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I
RU2018139074A RU2740910C2 (ru) 2016-04-08 2017-02-17 Офтальмологическая композиция, содержащая повидон-иод
AU2017247694A AU2017247694B2 (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising PVP-I
PL17714281.7T PL3439631T3 (pl) 2016-04-08 2017-02-17 Kompozycja okulistyczna obejmująca pvp-i
BR112018070734-1A BR112018070734B1 (pt) 2016-04-08 2017-02-17 Composição oftálmica e preparação farmacêutica
CN201780022544.XA CN108883064B (zh) 2016-04-08 2017-02-17 包含pvp-i的眼用组合物
US16/092,173 US20200000714A1 (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising pvp-i
MA044601A MA44601A (fr) 2016-04-08 2017-02-17 Composition ophtalmique contenant de la pvp-i
PCT/IB2017/050911 WO2017175075A1 (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising pvp-i
ES17714281T ES2950498T3 (es) 2016-04-08 2017-02-17 Composición oftálmica que comprende PVP-I
MX2018012311A MX385489B (es) 2016-04-08 2017-02-17 Composicion oftalmica que comprende pvp-i.
EP17714281.7A EP3439631B1 (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising pvp-i
PT177142817T PT3439631T (pt) 2016-04-08 2017-02-17 Composição oftálmica que compreende pvp-i
CA3019748A CA3019748C (en) 2016-04-08 2017-02-17 Ophthalmic composition comprising pvp-i
CL2018002861A CL2018002861A1 (es) 2016-04-08 2018-10-08 Composición oftálmica que comprende pvp-i.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITUA2016A002425A ITUA20162425A1 (it) 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I

Publications (1)

Publication Number Publication Date
ITUA20162425A1 true ITUA20162425A1 (it) 2017-10-08

Family

ID=56555535

Family Applications (1)

Application Number Title Priority Date Filing Date
ITUA2016A002425A ITUA20162425A1 (it) 2016-04-08 2016-04-08 Composizione oftalmica che comprende PVP-I

Country Status (14)

Country Link
US (1) US20200000714A1 (it)
EP (1) EP3439631B1 (it)
CN (1) CN108883064B (it)
AU (1) AU2017247694B2 (it)
CA (1) CA3019748C (it)
CL (1) CL2018002861A1 (it)
ES (1) ES2950498T3 (it)
IT (1) ITUA20162425A1 (it)
MA (1) MA44601A (it)
MX (1) MX385489B (it)
PL (1) PL3439631T3 (it)
PT (1) PT3439631T (it)
RU (1) RU2740910C2 (it)
WO (1) WO2017175075A1 (it)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108451903B (zh) * 2018-07-05 2019-03-22 广东腾骏动物药业股份有限公司 一种聚维酮碘溶液及其制备方法
US12472162B2 (en) * 2018-07-24 2025-11-18 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use
JP2021532182A (ja) * 2018-07-24 2021-11-25 オルソフォー，エルエルシー 外科消毒剤用の直ぐに使用できる最終的に滅菌した包装及び使用方法
CA3148359A1 (en) * 2019-08-18 2021-02-25 Bo Liang Stable pharmaceutical articles containing dilute povidone iodine formulations
CN110559175A (zh) * 2019-08-27 2019-12-13 陈文龙 一种结膜囊消毒溶液及其使用方法和装置
EP4100063A1 (en) * 2020-02-03 2022-12-14 Medivis S.r.l. Stable ophthalmic formulations based on low-concentration povidone iodide in plastic containers
WO2026139588A1 (en) 2024-12-23 2026-07-02 Zaklady Farmaceutyczne Polpharma Sa Ophtalmic pharmaceutical compositions for the treatment of conjunctivitis

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
US20070219170A1 (en) * 2006-03-14 2007-09-20 Samson C Michael Ophthalmic compositions comprising povidone-iodine
WO2013078998A1 (en) * 2011-11-29 2013-06-06 Jiangsu Deda Pharmaceuticals Co., Ltd Novel slow-releasing ophthalmic compositions comprising povidone iodine

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0323522A4 (en) * 1987-07-07 1989-08-30 Santen Pharmaceutical Co Ltd ARTIFICIAL TEAR.
NL9002049A (nl) * 1990-09-18 1992-04-16 Dagra Pharma Bv Oogheelkundig preparaat dat een povidon-joodoplossing bevat.
GB0413954D0 (en) * 2004-06-22 2004-07-28 Altunkaya Ali Compositions for topical treatment
EP2229174A1 (en) * 2007-12-04 2010-09-22 Novagali Pharma S.A. Compositions comprising corticosteroid prodrug such as dexamethasone palmitate for the treatment of eye disorders
BRPI0912302A2 (pt) * 2008-05-28 2015-10-20 Alcon Res Ltd emulsões autopreservados
AU2009258145A1 (en) * 2008-06-12 2009-12-17 Foresight Biotherapeutics, Inc. Povidone iodine, a novel alternative preservative for ophthalmic compositions
IT1404931B1 (it) * 2010-06-11 2013-12-09 Medivis S R L Composizioni oftalmiche per la somministrazione di principi attivi liposolubili .

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5863556A (en) * 1993-08-20 1999-01-26 Euro-Celtique, S.A. Preparations for the external application of antiseptic agents and/or agents promoting the healing of wounds
US20070219170A1 (en) * 2006-03-14 2007-09-20 Samson C Michael Ophthalmic compositions comprising povidone-iodine
WO2013078998A1 (en) * 2011-11-29 2013-06-06 Jiangsu Deda Pharmaceuticals Co., Ltd Novel slow-releasing ophthalmic compositions comprising povidone iodine

Also Published As

Publication number Publication date
MX385489B (es) 2025-03-18
EP3439631A1 (en) 2019-02-13
MA44601A (fr) 2019-02-13
MX2018012311A (es) 2019-05-22
WO2017175075A1 (en) 2017-10-12
AU2017247694A1 (en) 2018-10-25
RU2740910C2 (ru) 2021-01-21
BR112018070734A2 (pt) 2019-02-05
CN108883064A (zh) 2018-11-23
CA3019748C (en) 2024-01-09
ES2950498T3 (es) 2023-10-10
US20200000714A1 (en) 2020-01-02
RU2018139074A3 (it) 2020-06-30
PT3439631T (pt) 2023-07-28
CA3019748A1 (en) 2017-10-12
PL3439631T3 (pl) 2023-09-04
RU2018139074A (ru) 2020-05-12
CN108883064B (zh) 2022-09-16
AU2017247694B2 (en) 2022-04-21
CL2018002861A1 (es) 2019-02-22
EP3439631B1 (en) 2023-05-10

Similar Documents

Publication Publication Date Title
EP3588173A4 (en) Eyewear
DK3612531T3 (da) Apoptose-inducerende midler
EP3534711A4 (en) FUNGICIDE COMBINATIONS
BR112016030368A2 (pt) composição oftálmica
EP3291824A4 (en) ANTIMICROBIAL THERAPY
LT3426226T (lt) Oftalmologinė kompozicija
DK3416996T3 (da) Hærdelig sammensætning
EP3236978C0 (en) An antimicrobial composition
EP3415008A4 (en) GERMIC COMPOSITION
LT3386954T (lt) Dimeriniai kontrastiniai agentai
EP3521021A4 (en) HYDROGEL
EP3449930C0 (en) SYNAPSE TRAINING AGENT
HUE055835T2 (hu) Kapásnövény-betakarító
EP3500102C0 (en) ANTIMICROBIAL COMPOSITION
EP3598206A4 (en) GLASSES
EP3405581A4 (en) ANTIMICROBIAL PROTEINS
DK3452093T3 (da) Ophthalmiske sammensætninger
EP3373875A4 (en) BANDAGE
EP3308781A4 (en) BLOOD PRESSURE CENTER
PT3439631T (pt) Composição oftálmica que compreende pvp-i
EP3530711A4 (en) GEL COMPOSITION
BR112016018442A2 (pt) agentes antibacterianos
DK3393967T3 (da) Antimikrobiel polymersammensætning
FR3020948B1 (fr) Composition antimicrobienne
LT3344663T (lt) Penflufeno turinti polimero dalelė